Quick Answer
INVO Fertility, Inc. reported Research And Development Expense of $489.7 thousand for the year ending 2024.
- INVO Fertility, Inc. showed an increase of +195.1% in Research And Development Expense from 2023 to 2024.
- This data is from INVO Fertility, Inc.'s annual report (Form 10-K), filed with the SEC on April 30, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $0.00 | Q2 2019: $0.00 | Q3 2019: $0.00 | Q1 2020: $30.1 thousand | Q2 2020: $34.9 thousand | Q3 2020: $112.6 thousand | Q1 2021: $66.3 thousand | Q2 2021: $31.0 thousand | Q3 2021: $55.4 thousand | Q1 2022: $104.2 thousand | Q2 2022: $190.8 thousand | Q3 2022: $175.3 thousand | Q1 2023: $73.5 thousand | Q2 2023: $83.9 thousand | Q3 2023: $2.7 thousand | Q1 2024: $4.9 thousand | Q1 2025: $265.7 thousand.
- Historical annual values: Fiscal year 2024: $489.7 thousand | Fiscal year 2023: $165.9 thousand | Fiscal year 2022: $544.0 thousand | Fiscal year 2021: $216.4 thousand | Fiscal year 2020: $398.4 thousand | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: